Cognitive Decline after Delirium in Patients Undergoing Cardiac Surgery.
Charles H Brown, Julia Probert, Ryan Healy...
https://pubmed.ncbi.nlm.nih.gov/29771710/Actively Recruiting
Led by Chinese Academy of Medical Sciences, Fuwai Hospital · Updated on 2025-11-24
912
Participants Needed
5
Research Sites
52 weeks
Total Duration
Researchers are evaluating the NeuroFirst strategy, a combined anesthetic targets bundle aimed at protecting the brain, to see if it can reduce silent brain infarction SBI and perioperative neurocognitive disorders PND in adults undergoing cardiac surgery. This study compares the NeuroFirst approach with routine care following published guidelines. The trial also assesses the safety of this neuroprotective strategy. Participants are randomly assigned to either the NeuroFirst group or the routine care group. The NeuroFirst bundle focuses on managing mean arterial pressure MAP, bispectral index BIS, regional cerebral oxygen saturation rSO2, and arterial inflow temperature during cardiopulmonary bypass using various treatments and monitoring techniques. The routine care group receives standard management based on institutional guidelines. Throughout the study, participants will undergo brain MRI scans, and assessments using the Confusion Assessment Method and Montreal Cognitive Assessment. Researchers will monitor participants for up to one year after surgery, measuring the incidence of new silent brain infarctions within 7 days, neurocognitive disorders, delirium, strokes, transient ischemic attacks, and major adverse events at multiple time points. Safety and long-term outcomes will also be tracked during follow-up.
CONDITIONS
Interventions for Silent Brain Infarction and Perioperative Neurocognitive Disorders in Cardiovascular Surgery
J
Jia Shi, M.D.
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Chinese Academy of Medical Sciences, Fuwai Hospital
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Surgery day and intraoperative period
Participants undergo elective cardiovascular surgery with cardiopulmonary bypass. They are managed either with the NeuroFirst target bundle aimed at specific intraoperative physiological targets or with routine institutional management according to published guidelines.
1 surgical visit (in-person)
Duration - Up to 1 year postoperatively
Participants are monitored for new brain infarctions, neurocognitive disorders, delirium, stroke, and other major adverse events following surgery.
Visits at 7 days, 30 days, and up to 1 year after surgery
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Charles H Brown, Julia Probert, Ryan Healy...
https://pubmed.ncbi.nlm.nih.gov/29771710/M F Newman, J L Kirchner, B Phillips-Bute...
https://pubmed.ncbi.nlm.nih.gov/11172175/Suzan Uysal, Hung-Mo Lin, Muoi Trinh...
https://pubmed.ncbi.nlm.nih.gov/31056357/Ibrahim Sultan, Valentino Bianco, Arman Kilic...
https://pubmed.ncbi.nlm.nih.gov/32199830/Chun Cheng, Hanxi Wan, Peilin Cong...
https://pubmed.ncbi.nlm.nih.gov/36503642/Lu Wang, Shu Li, Philip James Devereaux...
https://pubmed.ncbi.nlm.nih.gov/42320960/Sarah E Vermeer, Niels D Prins, Tom den Heijer...
https://pubmed.ncbi.nlm.nih.gov/12660385/Jonathon P Fanning, Andrew A Wong, John F Fraser
https://pubmed.ncbi.nlm.nih.gov/25012298/Ben Indja, Kei Woldendorp, Michael P Vallely...
https://pubmed.ncbi.nlm.nih.gov/31017035/A Maheshwari, P J McCormick, D I Sessler...
https://pubmed.ncbi.nlm.nih.gov/28974062/Chinese Academy of Medical Sciences, Fuwai Hospital
Lead Sponsor